Insys Therapeutics Fakes Patients To Spur Sales

A United States cancer treatment centre Insys Therapeutic has been charged for allegedly sponsoring fake cancer patients in order to increse drug sales. The charge is coming on the heels of accusations tendered by Sen. Clair McCaskil a U.S. Democrat from Missouri.

The drug Subsys, a sprayable form of opiod painkiller fentanyl, was approved by the U..S. Food and Drug Administration in 2012 to treat acute pain in cancer patients. However, due to the high cost of Subsys insurace companies were unable to afford it except when approved in advance.

The faking process employed by Insys includes falsifying medical records, misleading insurance companies and providing kickbacks to doctors. This was released in a statement signed by McCaskill's office.

In order to increase sales, it is alleged that Insys took patients who did not have cancer and made it look like they did.

In a press statement signed by Insys and made available to CNN Insys disagrees with "certain characterisations in the staff report released today."

In 2016 U.S. Federal prosecutors criminally charged the the company's former CEO plus 5 other executives with fraud and racketeering charges  relating to Subsys.


Popular posts from this blog

Portuguese Billionaire Antonio Piera Passes to Coronavirus

NIMASA To Send IMO Instruments For Domestication

NPA To Pay Tally Clerks Outstanding Balance Soon.